Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

Ferula assafoetida as a Multi-Target Therapeutic Candidate for Parkinson's Disease: A Narrative Review

Journal of Tropical Life Science : International Journal of Theoretical, Experimental, and Applied Life Sciences · Vol. 16 No. 2 (2026) · hlm. 217–234

DOI
10.11594/jtls.16.02.01
ISSN
2527-4376, 2087-5517
Terbit
2026-08-11
Penerbit
Journal of Tropical Life Science
Bahasa
eng
Lisensi
creativecommons.org/licenses/by-nc/4.0

Abstrak

Parkinson’s disease (PD) presents a complex challenge in neurodegenerative research due to the persistent lack of disease-modifying therapies, prompting exploration of natural compounds with multi-target capabilities to modulate multiple pathways. Hence, this review evaluates the therapeutic potential of the ayurvedic plant, Ferula assafoetida, as a candidate for PD treatment. The phytochemical profile of F. assafoetida, rich in bioactive sulfur volatiles, phenolic acids, coumarins, and terpenes, aligns with mechanisms implicated in PD pathogenesis, including oxidative stress, inflammation, and mitochondrial dysfunction. Critically, recent activity-guided isolation studies have successfully identified specific sesquiterpene coumarins, such as karatavicinol and farnesiferol C, as potent monoamine oxidase-B (MAO-B) inhibitors, demonstrating efficacy in ameliorating motor deficits and protecting dopaminergic neurons in a murine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model of PD. This breakthrough provides the first direct experimental evidence for F. assafoetida in a PD model, transitioning its status from a traditional remedy to a source of validated, bioactive lead compounds. While mammalian models offer crucial translational validation, zebrafish, with their conserved dopaminergic pathways, genetic tractability, and suitability for high-throughput screening, emerge as an ideal complementary platform for accelerating future research. Advanced phytochemical profiling, integrating chromatographic methods and in silico molecular docking, could prioritize lead compounds for further investigation. The integration of gene expression analysis in zebrafish models, alongside behavioral assays, enables a comprehensive understanding of the impact of this plant on PD-related pathways. This pertinent evidence now positions F. assafoetida as a viable preclinical candidate. Future research should prioritize chemical standardization across different plant sources and in vivo mechanistic studies in zebrafish. By illustrating the synergy between phytochemistry and innovative model systems, this review lays the groundwork for exploring F. assafoetida as a promising candidate for novel PD therapies and related neurodegenerative disorders.

Kata kunci

Jaringan kolaborasi para penulis

35 penulis · 119 tautan kepenulisan bersama · 45 lintas organisasi

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • University of Technology Malaysia
  • International Islamic University Malaysia
  • National University of Malaysia
  • Mustansiriyah University
  • Hawler Medical University
  • Bani-Waleed University
  • Universiti Teknologi MARA
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Nor Wajihan MudaUniversity of Technology Malaysia2
Nur Nadiah Abdul RashidInternational Islamic University Malaysia2
Nurasyikin HamzahInternational Islamic University Malaysia2
Che Muhammad Khairul Hisyam IsmailInternational Islamic University Malaysia2
Siti Aishah Sufira Nor HishamuddinInternational Islamic University Malaysia2
Izzat Fahimuddin Mohamed SuffianInternational Islamic University Malaysia2
Fahrul HuyopUniversity of Technology Malaysia1
Yilmaz KayaAfiliasi tidak diketahui1
Roswanira Abdul WahabUniversity of Technology Malaysia1
Batool Hazim Abdul WahhabMustansiriyah University1
Nurul Fatin Syamimi Khairul AnuarUniversity of Technology Malaysia1
Marwan S.M. Al NimerHawler Medical University1
Nurul Hidayah SamsulrizalInternational Islamic University Malaysia1
Mohamed Faraj EdbeibBani-Waleed University1
Mohammad Rahim KamaluddinNational University of Malaysia1
Heo Chong ChinUniversiti Teknologi MARA1
Nur OmarUniversity of Technology Malaysia1
Zainoha ZakariaUniversity of Technology Malaysia1
Nurazira AnuarUniversity of Technology Malaysia1
Nur Faizah Moidu OmarUniversity of Technology Malaysia1
Aemi Syazwani Abdul KeyonUniversity of Technology Malaysia1
Mohammed Suhaimee Abd. ManafAfiliasi tidak diketahui1
Mohd Radzniwan A. RashidAfiliasi tidak diketahui1
Mohammad Rahim KamaluddinNational University of Malaysia1
Aedrianee Reeza AlwiUniversity of Technology Malaysia1
Faezah Mohd SallehUniversity of Technology Malaysia1
Seri Mirianti IsharNational University of Malaysia1
Nabihah AzharyInternational Islamic University Malaysia1
Mardiana Mohd AshaariInternational Islamic University Malaysia1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) http://jtrolis.ub.ac.id/index.php/jtrolis/oai, pertama di-harvest 9 Nov 2026, terakhir terlihat 16 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Ferula assafoetida as a Multi-Target Therapeutic Candidate for Parkinson's Disease: A Narrative Review</dc:title>
	<dc:creator xml:lang="en">Selvaraju, Anusia</dc:creator>
	<dc:creator xml:lang="en">Mahat, Naji Arafat</dc:creator>
	<dc:creator xml:lang="en">Jemon, Khairunadwa </dc:creator>
	<dc:creator xml:lang="en">Mohd Nasir, Mohd Hamzah</dc:creator>
	<dc:creator xml:lang="en">Abdul Hamid, Azzmer Azzar </dc:creator>
	<dc:creator xml:lang="en">Mohamed Huri, Mohamad Afiq </dc:creator>
	<dc:subject xml:lang="en">Ferula assafoetida</dc:subject>
	<dc:subject xml:lang="en"> Molecular docking</dc:subject>
	<dc:subject xml:lang="en">neurodegeneration</dc:subject>
	<dc:subject xml:lang="en">neuroprotection</dc:subject>
	<dc:subject xml:lang="en">Parkinson's disease</dc:subject>
	<dc:subject xml:lang="en">phytochemicals</dc:subject>
	<dc:subject xml:lang="en">zebrafish model</dc:subject>
	<dc:description xml:lang="en">Parkinson’s disease (PD) presents a complex challenge in neurodegenerative research due to the persistent lack of disease-modifying therapies, prompting exploration of natural compounds with multi-target capabilities to modulate multiple pathways. Hence, this review evaluates the therapeutic potential of the ayurvedic plant, Ferula assafoetida, as a candidate for PD treatment. The phytochemical profile of F. assafoetida, rich in bioactive sulfur volatiles, phenolic acids, coumarins, and terpenes, aligns with mechanisms implicated in PD pathogenesis, including oxidative stress, inflammation, and mitochondrial dysfunction. Critically, recent activity-guided isolation studies have successfully identified specific sesquiterpene coumarins, such as karatavicinol and farnesiferol C, as potent monoamine oxidase-B (MAO-B) inhibitors, demonstrating efficacy in ameliorating motor deficits and protecting dopaminergic neurons in a murine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model of PD. This breakthrough provides the first direct experimental evidence for F. assafoetida in a PD model, transitioning its status from a traditional remedy to a source of validated, bioactive lead compounds. While mammalian models offer crucial translational validation, zebrafish, with their conserved dopaminergic pathways, genetic tractability, and suitability for high-throughput screening, emerge as an ideal complementary platform for accelerating future research. Advanced phytochemical profiling, integrating chromatographic methods and in silico molecular docking, could prioritize lead compounds for further investigation. The integration of gene expression analysis in zebrafish models, alongside behavioral assays, enables a comprehensive understanding of the impact of this plant on PD-related pathways. This pertinent evidence now positions F. assafoetida as a viable preclinical candidate. Future research should prioritize chemical standardization across different plant sources and in vivo mechanistic studies in zebrafish. By illustrating the synergy between phytochemistry and innovative model systems, this review lays the groundwork for exploring F. assafoetida as a promising candidate for novel PD therapies and related neurodegenerative disorders.</dc:description>
	<dc:publisher xml:lang="en">Journal of Tropical Life Science</dc:publisher>
	<dc:date>2026-08-11</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jtrolis.ub.ac.id/index.php/jtrolis/article/view/3933</dc:identifier>
	<dc:identifier>10.11594/jtls.16.02.01</dc:identifier>
	<dc:source xml:lang="en">Journal of Tropical Life Science; Vol. 16 No. 2 (2026); 217 - 234</dc:source>
	<dc:source>2527-4376</dc:source>
	<dc:source>2087-5517</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://jtrolis.ub.ac.id/index.php/jtrolis/article/view/3933/842</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 2026 Journal of Tropical Life Science</dc:rights>
	<dc:rights xml:lang="en">https://creativecommons.org/licenses/by-nc/4.0</dc:rights>
</oai_dc:dc>